Insider · CIK 0001408502

Hahn Mark W

Reports to the SEC for 6 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001408502

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-18	SOLENO THERAPEUTICS INCD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2025-10-13	SOLENO THERAPEUTICS INCA Award	Director	AAward	+10K sh	—	—	10,046
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−390K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−446K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−800K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitA Award	Chief Financial Officer	AAward	+1.65M sh	—	—	1,649,952
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1.65M sh	—	—	0
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−3.29M sh	—	—	0
2025-10-07	VRNAVerona Pharma plcM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3.29M sh	—	—	3,285,280
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−11.3M sh	—	—	0
2025-08-29	VRNAVerona Pharma plcG Gift	Chief Financial Officer	GGift	−1.2M sh	—	—	11,264,968
2025-08-01	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−209K sh	$13.14	−$2.75M	12,464,968
2025-08-01	VRNAVerona Pharma plcM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+256K sh	—	—	12,673,880
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−200K sh	—	—	800,000
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−55.7K sh	—	—	389,792
2025-07-08	VRNAVerona Pharma plcF Tax Payment	Chief Financial Officer	FTax Payment	−90.3K sh	$11.44	−$1.03M	12,418,184
2025-07-07	VRNAVerona Pharma plcM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+230K sh	—	—	12,508,504
2025-07-07	VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−230K sh	—	—	445,536
2025-07-07	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Chief Financial Officer	AAward	+675K sh	—	—	675,048
2025-06-11	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−400K sh	$11.40	−$4.56M	12,278,992
2025-05-29	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−205K sh	$9.33	−$1.91M	12,678,992
2025-05-28	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−163K sh	$9.30	−$1.51M	12,883,856
2025-05-27	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−32.4K sh	$9.53	−$309K	13,046,560
2025-05-02	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−400K sh	$9.09	−$3.64M	13,078,992
2025-05-01	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−108K sh	$8.95	−$969K	13,357,728
2025-05-01	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−78.7K sh	$8.95	−$705K	13,478,992
2025-05-01	VRNAVerona Pharma plcM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+200K sh	—	—	13,557,728
2025-05-01	VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−200K sh	—	—	1,000,000
2025-04-29	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Chief Financial Officer	AAward	+675K sh	—	—	675,000
2025-04-29	VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−230K sh	—	—	445,488
2025-04-29	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−90.4K sh	$8.98	−$811K	13,466,000
2025-04-29	VRNAVerona Pharma plcM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+230K sh	—	—	13,556,360
2025-02-03	VRNAVerona Pharma plcF Tax Payment	Chief Financial Officer	FTax Payment	−167K sh	$7.16	−$1.2M	13,326,848
2025-02-01	VRNAVerona Pharma plcA Award	Chief Financial Officer	AAward	+200K sh	—	—	13,493,736
2024-12-06	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−184K sh	$5.01	−$920K	13,293,736
2024-12-05	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−640K sh	$5.01	−$3.2M	13,477,464
2024-12-04	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−58.2K sh	$5.00	−$291K	14,117,512
2024-12-02	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−1,600 sh	$5.00	−$8,000	14,175,696
2024-11-29	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−98.7K sh	$5.01	−$494K	14,177,296
2024-11-27	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−12.9K sh	$5.00	−$64.7K	14,276,000
2024-11-26	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−800 sh	$5.00	−$4,000	14,288,936
2024-11-25	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−1,600 sh	$5.00	−$8,000	14,289,736
2024-11-11	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−2,400 sh	$5.00	−$12K	14,291,336
2024-11-04	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−80.8K sh	$4.39	−$354K	14,293,736
2024-11-01	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−48.9K sh	$4.38	−$214K	14,374,520
2024-11-01	VRNAVerona Pharma plcA Award	Chief Financial Officer	AAward	+200K sh	—	—	14,669,360
2024-11-01	VRNAVerona Pharma plcF Tax Payment	Chief Financial Officer	FTax Payment	−246K sh	$4.24	−$1.04M	14,423,408
2024-10-30	VRNAVerona Pharma plcA Award	Chief Financial Officer	AAward	+800K sh	—	—	14,469,360
2024-10-25	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−3,200 sh	$4.38	−$14K	13,669,360
2024-10-24	VRNAVerona Pharma plcS Sale	Chief Financial Officer	SSale	−141K sh	$4.38	−$619K	13,672,560

Recent filings

Accepted (ET)
May 184
Hahn Mark W0001408502-26-000001
SEC(opens sec.gov)
Oct 144
Hahn Mark W0001408502-25-000008
SEC(opens sec.gov)
Oct 84
Hahn Mark W0001104659-25-097962
SEC(opens sec.gov)
Sep 34
Hahn Mark W0001104659-25-087055
SEC(opens sec.gov)
Aug 54
Hahn Mark W0001104659-25-074398
SEC(opens sec.gov)
Jul 94
Hahn Mark W0001104659-25-066766
SEC(opens sec.gov)
Jun 134
Hahn Mark W0001104659-25-059403
SEC(opens sec.gov)

Companies

Address

100 MARINE PARKWAY, SUITE 400

REDWOOD CITY, CA, 94065